Literature DB >> 20089651

Extralymphoid CD8+ T cells resident in tissue from simian immunodeficiency virus SIVmac239{Delta}nef-vaccinated macaques suppress SIVmac239 replication ex vivo.

Justin M Greene1, Jennifer J Lhost, Benjamin J Burwitz, Melisa L Budde, Caitlin E Macnair, Madelyn K Weiker, Emma Gostick, Thomas C Friedrich, Karl W Broman, David A Price, Shelby L O'Connor, David H O'Connor.   

Abstract

Live-attenuated vaccination with simian immunodeficiency virus (SIV) SIVmac239Deltanef is the most successful vaccine product tested to date in macaques. However, the mechanisms that explain the efficacy of this vaccine remain largely unknown. We utilized an ex vivo viral suppression assay to assess the quality of the immune response in SIVmac239Deltanef-immunized animals. Using major histocompatibility complex-matched Mauritian cynomolgus macaques, we did not detect SIV-specific functional immune responses in the blood by gamma interferon (IFN-gamma) enzyme-linked immunospot assay at select time points; however, we found that lung CD8(+) T cells, unlike blood CD8(+) T cells, effectively suppress virus replication by up to 80%. These results suggest that SIVmac239Deltanef may be an effective vaccine because it elicits functional immunity at mucosal sites. Moreover, these results underscore the limitations of relying on immunological measurements from peripheral blood lymphocytes in studies of protective immunity to HIV/SIV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089651      PMCID: PMC2838091          DOI: 10.1128/JVI.02028-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.

Authors:  L Sernicola; F Corrias; M L Koanga-Mogtomo; S Baroncelli; S Di Fabio; M T Maggiorella; R Belli; Z Michelini; I Macchia; A Cesolini; L Cioè; P Verani; F Titti
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

2.  Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection.

Authors:  Richard Stebbings; Neil Berry; Jim Stott; Robin Hull; Barry Walker; Jenny Lines; William Elsley; Stuart Brown; Alison Wade-Evans; Gail Davis; Jenny Cowie; Meera Sethi; Neil Almond
Journal:  Virology       Date:  2004-12-05       Impact factor: 3.616

3.  Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.

Authors:  R Stebbings; J Stott; N Almond; R Hull; J Lines; P Silvera; R Sangster; T Corcoran; J Rose; S Cobbold; F Gotch; A McMichael; B Walker
Journal:  AIDS Res Hum Retroviruses       Date:  1998-09-01       Impact factor: 2.205

4.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection.

Authors:  F Javier Ibarrondo; Peter A Anton; Marie Fuerst; Hwee L Ng; Johnson T Wong; Jose Matud; Julie Elliott; Roger Shih; Mary Ann Hausner; Charles Price; Lance E Hultin; Patricia M Hultin; Beth D Jamieson; Otto O Yang
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus.

Authors:  M A Cromwell; R S Veazey; J D Altman; K G Mansfield; R Glickman; T M Allen; D I Watkins; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

Authors:  R P Johnson; J D Lifson; S C Czajak; K S Cole; K H Manson; R Glickman; J Yang; D C Montefiori; R Montelaro; M S Wyand; R C Desrosiers
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.

Authors:  M S Wyand; K Manson; D C Montefiori; J D Lifson; R P Johnson; R C Desrosiers
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 9.  Protective immunity induced by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R C Desrosiers
Journal:  Curr Opin Immunol       Date:  1998-08       Impact factor: 7.486

10.  Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

Authors:  Louis J Picker; Shoko I Hagen; Richard Lum; Edward F Reed-Inderbitzin; Lyn M Daly; Andrew W Sylwester; Joshua M Walker; Don C Siess; Michael Piatak; Chenxi Wang; David B Allison; Vernon C Maino; Jeffrey D Lifson; Toshiaki Kodama; Michael K Axthelm
Journal:  J Exp Med       Date:  2004-11-15       Impact factor: 14.307

View more
  20 in total

1.  Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.

Authors:  Melisa L Budde; Jennifer J Lhost; Benjamin J Burwitz; Ericka A Becker; Charles M Burns; Shelby L O'Connor; Julie A Karl; Roger W Wiseman; Benjamin N Bimber; Guang Lan Zhang; William Hildebrand; Vladimir Brusic; David H O'Connor
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.

Authors:  Cédric Sapet; Christophe Pellegrino; Nicolas Laurent; Flavie Sicard; Olivier Zelphati
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

3.  Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys.

Authors:  Kathryn E Stephenson; Hualin Li; Bruce D Walker; Nelson L Michael; Dan H Barouch
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

4.  The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages.

Authors:  Lara Vojnov; Mauricio A Martins; Alexander T Bean; Marlon G Veloso de Santana; Jonah B Sacha; Nancy A Wilson; Myrna C Bonaldo; Ricardo Galler; Mario Stevenson; David I Watkins
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 5.  New approaches to design HIV-1 T-cell vaccines.

Authors:  Hélène Perrin; Glenda Canderan; Rafick-Pierre Sékaly; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

6.  Expansion of Simian Immunodeficiency Virus (SIV)-Specific CD8 T Cell Lines from SIV-Naive Mauritian Cynomolgus Macaques for Adoptive Transfer.

Authors:  Mariel S Mohns; Justin M Greene; Brian T Cain; Ngoc H Pham; Emma Gostick; David A Price; David H O'Connor
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

7.  Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys.

Authors:  Hualin Li; Jinyan Liu; Angela Carville; Keith G Mansfield; Diana Lynch; Dan H Barouch
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

8.  Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.

Authors:  Sunil K Khattar; Senthilkumar Palaniyandi; Sweety Samal; Celia C LaBranche; David C Montefiori; Xiaoping Zhu; Siba K Samal
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Adoptive transfer of lymphocytes isolated from simian immunodeficiency virus SIVmac239Δnef-vaccinated macaques does not affect acute-phase viral loads but may reduce chronic-phase viral loads in major histocompatibility complex-matched recipients.

Authors:  Justin M Greene; Jennifer J Lhost; Paul J Hines; Matthew Scarlotta; Max Harris; Benjamin J Burwitz; Melisa L Budde; Dawn M Dudley; Ngoc Pham; Brian Cain; Caitlin E Mac Nair; Madelyn K Weiker; Shelby L O'Connor; Thomas C Friedrich; David H O'Connor
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Characterization of full-length MHC class II sequences in Indonesian and Vietnamese cynomolgus macaques.

Authors:  Hannah M Creager; Ericka A Becker; Kelly K Sandman; Julie A Karl; Simon M Lank; Benjamin N Bimber; Roger W Wiseman; Austin L Hughes; Shelby L O'Connor; David H O'Connor
Journal:  Immunogenetics       Date:  2011-05-26       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.